Evidence map›Paper›PMID 7914698›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice.

B A Bamber, B A Masters, G W Hoyle, R L Brinster, R D Palmiter

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Transgenic models of pancreatic cancer.International journal of gastrointestinal cancer · 2003
    Review
  11. Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
  12. Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  13. Nerve growth factor antiserum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2001
    Article
  14. Review
  15. Article
  16. Article
  17. The expression pattern of the transcription factor Phox2 delineates synaptic pathways of the autonomic nervous system.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1996
    Article
  18. Article
  19. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B A BamberDepartment of Biochemistry, University of Washington, Seattle 98195.
B A Masters
G W Hoyle
R L Brinster
R D Palmiter
University of Washington · US

Funding

REGULATION OF METALLOTHIONEIN GENE EXPRESSIONR01HD009172 · NICHD · UNIVERSITY OF WASHINGTON · PI PALMITER, RICHARD D · 1985 to 1987
–
TRANSGENIC APPROACHES TO NERVOUS SYSTEM DEVELOPMENTR37HD009172 · NICHD · UNIVERSITY OF WASHINGTON · PI PALMITER, RICHARD D · 1988 to 1997
–
MALE GERM CELL DEVELOPMENT IN TRANSGENIC MICER37HD023657 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI BRINSTER, RALPH LAWRENCE · 1988 to 1997
–
NICHD NIH HHS HD-09172NICHD NIH HHS HD-23657
6 · The paper itself

Abstract

Leukemia inhibitory factor (LIF) is a cytokine growth factor that induces rat sympathetic neurons to switch their neurotransmitter phenotype from noradrenergic to cholinergic in vitro. To test whether LIF can influence neuronal differentiation in vivo, we generated transgenic mice that expressed LIF in pancreatic islets under the control of the insulin promoter and evaluated the neurotransmitter phenotype of the pancreatic sympathetic innervation. We also used the insulin promoter to coexpress nerve growth factor in the islets, which greatly increased the density of sympathetic innervation and facilitated analysis of the effects of LIF. Our data demonstrate that tyrosine hydroxylase and catecholamines declined and choline acetyltransferase increased in response to LIF. We conclude that LIF can induce neurotransmitter switching of sympathetic neurons in vivo.

Indexed as

Interleukin-6AgingAnimalsCatecholaminesCell DifferentiationCholine O-AcetyltransferaseCrosses, GeneticFemaleGene ExpressionGrowth InhibitorsHumansImmunohistochemistryInsulinIslets of LangerhansLeukemia Inhibitory FactorLymphokinesCatecholaminesCholine O-AcetyltransferaseGrowth InhibitorsInsulinInterleukin-6Leukemia Inhibitory FactorLIF protein, humanLif protein, mouseLymphokinesNerve Growth FactorsTyrosine 3-Monooxygenase

Identifiers

PMID7914698
PMCPMC44499
OpenAlexW1975011053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.